chr19-49054307-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001385261.1(CGB7):c.482C>A(p.Pro161Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000125 in 1,600,616 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001385261.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CGB7 | NM_001385261.1 | c.482C>A | p.Pro161Gln | missense_variant | 5/5 | ENST00000684222.1 | NP_001372190.1 | |
CGB7 | NM_033142.2 | c.482C>A | p.Pro161Gln | missense_variant | 5/5 | NP_149133.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CGB7 | ENST00000684222.1 | c.482C>A | p.Pro161Gln | missense_variant | 5/5 | NM_001385261.1 | ENSP00000507822.1 | |||
CGB7 | ENST00000596965.5 | c.482C>A | p.Pro161Gln | missense_variant | 5/5 | 2 | ENSP00000469076.1 | |||
CGB7 | ENST00000597853.5 | c.482C>A | p.Pro161Gln | missense_variant | 5/5 | 2 | ENSP00000470813.1 |
Frequencies
GnomAD3 genomes AF: 0.00000661 AC: 1AN: 151350Hom.: 0 Cov.: 27
GnomAD3 exomes AF: 0.00000429 AC: 1AN: 232976Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 125840
GnomAD4 exome AF: 6.90e-7 AC: 1AN: 1449266Hom.: 0 Cov.: 45 AF XY: 0.00000139 AC XY: 1AN XY: 719904
GnomAD4 genome AF: 0.00000661 AC: 1AN: 151350Hom.: 0 Cov.: 27 AF XY: 0.00 AC XY: 0AN XY: 73842
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2023 | The c.482C>A (p.P161Q) alteration is located in exon 3 (coding exon 3) of the CGB7 gene. This alteration results from a C to A substitution at nucleotide position 482, causing the proline (P) at amino acid position 161 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at